BIOMAT Database Logo BIOMAT Database Logo

Cytomegalovirus prophylaxis in solid organ transplant recipients. 1996

R Patel, and D R Snydman, and R H Rubin, and M Ho, and M Pescovitz, and M Martin, and C V Paya
Division of Infectious Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014180 Transplantation Transference of a tissue or organ from either an alive or deceased donor, within an individual, between individuals of the same species, or between individuals of different species. Transplantations
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D015774 Ganciclovir An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. BIOLF-62,BW-759,Cytovene,Ganciclovir Sodium,Ganciclovir, Monosodium Salt,Gancyclovir,RS-21592

Related Publications

R Patel, and D R Snydman, and R H Rubin, and M Ho, and M Pescovitz, and M Martin, and C V Paya
Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients.
July 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
R Patel, and D R Snydman, and R H Rubin, and M Ho, and M Pescovitz, and M Martin, and C V Paya
Cytomegalovirus prophylaxis in solid organ transplant recipients: the issues.
March 2000, Transplantation proceedings,
R Patel, and D R Snydman, and R H Rubin, and M Ho, and M Pescovitz, and M Martin, and C V Paya
Cytomegalovirus in solid organ transplant recipients.
December 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
R Patel, and D R Snydman, and R H Rubin, and M Ho, and M Pescovitz, and M Martin, and C V Paya
Cytomegalovirus infection in solid organ transplant recipients.
September 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
R Patel, and D R Snydman, and R H Rubin, and M Ho, and M Pescovitz, and M Martin, and C V Paya
Antifungal prophylaxis in solid organ transplant recipients.
May 2011, Expert review of anti-infective therapy,
R Patel, and D R Snydman, and R H Rubin, and M Ho, and M Pescovitz, and M Martin, and C V Paya
Recurrent cytomegalovirus disease in solid-organ transplant recipients.
October 1995, Transplantation proceedings,
R Patel, and D R Snydman, and R H Rubin, and M Ho, and M Pescovitz, and M Martin, and C V Paya
Relapsing cytomegalovirus infection in solid organ transplant recipients.
December 2009, Transplant infectious disease : an official journal of the Transplantation Society,
R Patel, and D R Snydman, and R H Rubin, and M Ho, and M Pescovitz, and M Martin, and C V Paya
Cost of prophylaxis in the management of cytomegalovirus infection in solid organ transplant recipients.
January 2007, Clinical transplantation,
R Patel, and D R Snydman, and R H Rubin, and M Ho, and M Pescovitz, and M Martin, and C V Paya
Antiviral dosing and efficacy for prophylaxis of cytomegalovirus disease in solid organ transplant recipients.
October 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
R Patel, and D R Snydman, and R H Rubin, and M Ho, and M Pescovitz, and M Martin, and C V Paya
Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients.
September 2011, Transplant international : official journal of the European Society for Organ Transplantation,
Copied contents to your clipboard!